Mitochondria Inborn Errors of Metabolism and ANT Defects in Mitochondria Diseases
NCT ID: NCT00786539
Last Updated: 2022-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2006-10-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This research study brings together many clinical sub-specialists to address the etiology of these disorders and to develop more effective approaches for their diagnoses and more reliable prognoses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mitochondrial DNA in Vitreous Fluid and Blood in Patients With Eye Disease or Ocular Trauma.
NCT04334499
Natural History, Pathogenesis, and Outcome of Ocular Disorders
NCT02821767
Nicotinamide Riboside and Mitochondrial Biogenesis
NCT03432871
Natural History of Eye Diseases Related to ABCA4 Mutations
NCT01736293
Macular Pigment Measurements in Eye & Other Tissues
NCT03022773
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diffuse Optical Spectroscopy
mitochondria
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Day
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beckman Laser Institute and Medical Center
Virginia Kimonis, MD, MRCP
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bruce J Tromberg, PhD
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institute University of California Irvine
Virginia Kimonis, MD
Role: PRINCIPAL_INVESTIGATOR
UCIMC Pediatrics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beckman Laser Institute Medical clinic
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20022608
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.